IE
Insider Edges

CATALYS PACIFIC, LLC 13F portfolio summary

CATALYS PACIFIC, LLC of CATALYS PACIFIC, LLC has 2 current stock holdings with a reported portfolio value of $229.5M. The portfolio 1 year return is +91.60%. Top holdings include MLYS (92.94%), PHAT (7.06%).

Back to investors

CATALYS PACIFIC, LLC 13F Portfolio

CATALYS PACIFIC, LLC
Latest SEC 13F filing: 2026-06-30

CATALYS PACIFIC, LLC runs CATALYS PACIFIC, LLC and currently holds 2 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $229.45M. Their top holdings are MLYS, PHAT. The top five represent 100.0% of reported portfolio weight. CATALYS PACIFIC, LLC ranks #134 out of 1000 investors tracked by Alpha Score. Their current best-performing preview position is MLYS with returns of -0.41%.

Sign in to enable email alerts for this investor.
Top 5 Holdings
MLYS92.9%
PHAT7.1%
Top 5: 100.0%
Portfolio Returns
1 Year
+91.60%
#67/1000
3 Year
+133.85%
#144/1000
5 Year
+133.85%
#148/1000

Portfolio Value

$229.45M

Alpha Score

112.0

#134 of 1000

Holdings

2

Showper page

CATALYS PACIFIC, LLC Current 13F Holdings

Reported holdings from CATALYS PACIFIC, LLC's latest SEC 13F filing, ranked by portfolio weight.

2 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change
MLYS
Mineralys Therapeutics, Inc.
92.94%$8.81$23.37+165.27%
Held
PHAT
Phathom Pharmaceuticals, Inc.
7.06%$12.89$7.25-43.75%
Held